Novo Nordisk, Xinbang pharmaceutical 5 varieties 7 product regulation in Jilin price reduction!
-
Last Update: 2019-03-21
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On February 20, Jilin Public Resources Trading Center announced that it would adjust the price limit or execution price of degu insulin and other drugs produced by Novo Nordisk (China) Pharmaceutical Co., Ltd and Guizhou Xinbang Pharmaceutical Co., Ltd Among them, two specifications of insulin injection, including 3ml: 300 unit (Refill) and 3ml: 300 unit (changchong), were reduced from 215.76 yuan to 181.03 yuan and 222.72 yuan to 191.44 yuan, respectively In addition, 5 specifications of Guizhou Xinbang pharmaceutical such as Maixuekang capsule, Yixinshu capsule, Zhenqifuzheng capsule and Huganning tablet were also reduced by 1-7 yuan Details are as follows:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
